List of Tables

Table 1. Coronary Heart Disease Medication Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Coronary Heart Disease Medication Market Restraints

Table 3. Coronary Heart Disease Medication Market Trends

Table 4. Coronary Heart Disease Medication Industry Policy

Table 5. Global Coronary Heart Disease Medication Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Coronary Heart Disease Medication Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global Coronary Heart Disease Medication Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 8. Global Coronary Heart Disease Medication Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 9. Global Coronary Heart Disease Medication Average Selling Price (ASP) by Company, (2020-2025) & (US$/Unit)

Table 10. Global Coronary Heart Disease Medication Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Coronary Heart Disease Medication Mergers & Acquisitions, Expansion Plans

Table 12. Global Coronary Heart Disease Medication Manufacturers Product Type

Table 13. Head Office and Coronary Heart Disease Medication Production Site of Key Manufacturer

Table 14. Coronary Heart Disease Medication Capacity of Major Manufacturers and Future Plan

Table 15. China Coronary Heart Disease Medication Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 16. China Coronary Heart Disease Medication Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 17. China Coronary Heart Disease Medication Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 18. China Coronary Heart Disease Medication Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 19. Global Coronary Heart Disease Medication Production & Forecast by Region, 2020 VS 2024 VS 2031, (K Units)

Table 20. Global Coronary Heart Disease Medication Production by Region, 2020-2025, (K Units)

Table 21. Global Coronary Heart Disease Medication Production Forecast by Region, 2026-2031, (K Units)

Table 22. Global Key Players of Coronary Heart Disease Medication Upstream (Raw Materials)

Table 23. Global Coronary Heart Disease Medication Typical Customers

Table 24. Coronary Heart Disease Medication Typical Distributors

Table 25. by Type, Global Coronary Heart Disease Medication Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 26. by Application, Global Coronary Heart Disease Medication Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 27. By Region, Global Coronary Heart Disease Medication Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 28. By Region, Global Coronary Heart Disease Medication Consumption Value, 2020-2031, US$ Million

Table 29. By Region, Global Coronary Heart Disease Medication Sales Quantity, 2020-2031, (K Units)

Table 30. By Country, Global Coronary Heart Disease Medication Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 31. By Country, Global Coronary Heart Disease Medication Consumption Value, 2020-2031, US$ Million

Table 32. By Country, Global Coronary Heart Disease Medication Consumption Value Market Share, 2020-2031

Table 33. By Country, Global Coronary Heart Disease Medication Sales Quantity, 2020-2031, (K Units)

Table 34. By Country, Global Coronary Heart Disease Medication Sales Quantity Market Share, 2020-2031

Table 35. AstraZeneca Company Information, Head Office, Market Area, and Industry Position

Table 36. AstraZeneca Coronary Heart Disease Medication Models, Specifications, and Application

Table 37. AstraZeneca Coronary Heart Disease Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 38. AstraZeneca Company Profile and Main Business

Table 39. AstraZeneca Recent Developments

Table 40. Pfizer Company Information, Head Office, Market Area, and Industry Position

Table 41. Pfizer Coronary Heart Disease Medication Models, Specifications, and Application

Table 42. Pfizer Coronary Heart Disease Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 43. Pfizer Company Profile and Main Business

Table 44. Pfizer Recent Developments

Table 45. Novartis Company Information, Head Office, Market Area, and Industry Position

Table 46. Novartis Coronary Heart Disease Medication Models, Specifications, and Application

Table 47. Novartis Coronary Heart Disease Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 48. Novartis Company Profile and Main Business

Table 49. Novartis Recent Developments

Table 50. Merck & Co Company Information, Head Office, Market Area, and Industry Position

Table 51. Merck & Co Coronary Heart Disease Medication Models, Specifications, and Application

Table 52. Merck & Co Coronary Heart Disease Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 53. Merck & Co Company Profile and Main Business

Table 54. Merck & Co Recent Developments

Table 55. Bayer Company Information, Head Office, Market Area, and Industry Position

Table 56. Bayer Coronary Heart Disease Medication Models, Specifications, and Application

Table 57. Bayer Coronary Heart Disease Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 58. Bayer Company Profile and Main Business

Table 59. Bayer Recent Developments

Table 60. Buchang Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 61. Buchang Pharmaceutical Coronary Heart Disease Medication Models, Specifications, and Application

Table 62. Buchang Pharmaceutical Coronary Heart Disease Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 63. Buchang Pharmaceutical Company Profile and Main Business

Table 64. Buchang Pharmaceutical Recent Developments

Table 65. China Resources Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 66. China Resources Pharmaceutical Coronary Heart Disease Medication Models, Specifications, and Application

Table 67. China Resources Pharmaceutical Coronary Heart Disease Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 68. China Resources Pharmaceutical Company Profile and Main Business

Table 69. China Resources Pharmaceutical Recent Developments

Table 70. Tasly Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 71. Tasly Pharmaceutical Coronary Heart Disease Medication Models, Specifications, and Application

Table 72. Tasly Pharmaceutical Coronary Heart Disease Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 73. Tasly Pharmaceutical Company Profile and Main Business

Table 74. Tasly Pharmaceutical Recent Developments

Table 75. Yiling Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 76. Yiling Pharmaceutical Coronary Heart Disease Medication Models, Specifications, and Application

Table 77. Yiling Pharmaceutical Coronary Heart Disease Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 78. Yiling Pharmaceutical Company Profile and Main Business

Table 79. Yiling Pharmaceutical Recent Developments

Table 80. China Shineway Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 81. China Shineway Pharmaceutical Coronary Heart Disease Medication Models, Specifications, and Application

Table 82. China Shineway Pharmaceutical Coronary Heart Disease Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 83. China Shineway Pharmaceutical Company Profile and Main Business

Table 84. China Shineway Pharmaceutical Recent Developments

Table 85. Shanghai Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 86. Shanghai Pharmaceuticals Coronary Heart Disease Medication Models, Specifications, and Application

Table 87. Shanghai Pharmaceuticals Coronary Heart Disease Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 88. Shanghai Pharmaceuticals Company Profile and Main Business

Table 89. Shanghai Pharmaceuticals Recent Developments

Table 90. Green Valley Company Information, Head Office, Market Area, and Industry Position

Table 91. Green Valley Coronary Heart Disease Medication Models, Specifications, and Application

Table 92. Green Valley Coronary Heart Disease Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 93. Green Valley Company Profile and Main Business

Table 94. Green Valley Recent Developments

Table 95. North China Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 96. North China Pharmaceutical Coronary Heart Disease Medication Models, Specifications, and Application

Table 97. North China Pharmaceutical Coronary Heart Disease Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 98. North China Pharmaceutical Company Profile and Main Business

Table 99. North China Pharmaceutical Recent Developments

Table 100. PKU HealthCare Company Information, Head Office, Market Area, and Industry Position

Table 101. PKU HealthCare Coronary Heart Disease Medication Models, Specifications, and Application

Table 102. PKU HealthCare Coronary Heart Disease Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 103. PKU HealthCare Company Profile and Main Business

Table 104. PKU HealthCare Recent Developments

Table 105. Zhejiang Ruibang Laboratories Company Information, Head Office, Market Area, and Industry Position

Table 106. Zhejiang Ruibang Laboratories Coronary Heart Disease Medication Models, Specifications, and Application

Table 107. Zhejiang Ruibang Laboratories Coronary Heart Disease Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 108. Zhejiang Ruibang Laboratories Company Profile and Main Business

Table 109. Zhejiang Ruibang Laboratories Recent Developments

List of Figures

Figure 1. Coronary Heart Disease Medication Picture

Figure 2. Global Coronary Heart Disease Medication Consumption Value, (US$ million) & (2020-2031)

Figure 3. Global Coronary Heart Disease Medication Sales Quantity, (K Units) & (2020-2031)

Figure 4. Global Coronary Heart Disease Medication Average Selling Price (ASP), (2020-2031) & (US$/Unit)

Figure 5. China Coronary Heart Disease Medication Consumption Value, (US$ million) & (2020-2031)

Figure 6. China Coronary Heart Disease Medication Sales Quantity (K Units) & (2020-2031)

Figure 7. China Coronary Heart Disease Medication Average Selling Price (ASP), (US$/Unit) & (2020-2031)

Figure 8. By Consumption Value, China Coronary Heart Disease Medication Market Share of Global, 2020-2031

Figure 9. By Sales Quantity, China Coronary Heart Disease Medication Market Share of Global, 2020-2031

Figure 10. Global Coronary Heart Disease Medication Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 11. China Coronary Heart Disease Medication Key Participants, Market Share, 2024

Figure 12. Global Coronary Heart Disease Medication Capacity, Production and Capacity Utilization, 2020-2031

Figure 13. Global Coronary Heart Disease Medication Capacity Market Share by Region, 2024 VS 2031

Figure 14. Global Coronary Heart Disease Medication Production Market Share & Forecast by Region, 2020-2031

Figure 15. Coronary Heart Disease Medication Industry Chain

Figure 16. Coronary Heart Disease Medication Procurement Model

Figure 17. Coronary Heart Disease Medication Sales Model

Figure 18. Coronary Heart Disease Medication Sales Channels, Direct Sales, and Distribution

Figure 19. Nitrates

Figure 20. Thrombolytic Drugs

Figure 21. β - receptor Blockers

Figure 22. Calcium Channel Blockers

Figure 23. Renin Angiotensin System Inhibitors

Figure 24. Statins

Figure 25. Proprietary Chinese Medicines

Figure 26. Others

Figure 27. by Type, Global Coronary Heart Disease Medication Consumption Value, 2020-2031, US$ Million

Figure 28. by Type, Global Coronary Heart Disease Medication Consumption Value Market Share, 2020-2031

Figure 29. by Type, Global Coronary Heart Disease Medication Sales Quantity, 2020-2031, (K Units)

Figure 30. by Type, Global Coronary Heart Disease Medication Sales Quantity Market Share, 2020-2031

Figure 31. by Type, Global Coronary Heart Disease Medication Average Selling Price (ASP), 2020-2031, (US$/Unit)

Figure 32. Hospital

Figure 33. Clinic

Figure 34. Others

Figure 35. by Application, Global Coronary Heart Disease Medication Consumption Value, 2020-2031, US$ Million

Figure 36. by Application, Global Coronary Heart Disease Medication Revenue Market Share, 2020-2031

Figure 37. by Application, Global Coronary Heart Disease Medication Sales Quantity, 2020-2031, (K Units)

Figure 38. by Application, Global Coronary Heart Disease Medication Sales Quantity Market Share, 2020-2031

Figure 39. by Application, Global Coronary Heart Disease Medication Price, 2020-2031, (US$/Unit)

Figure 40. By Region, Global Coronary Heart Disease Medication Consumption Value Market Share, 2020-2031

Figure 41. By Region, Global Coronary Heart Disease Medication Sales Quantity Market Share, 2020-2031

Figure 42. North America Coronary Heart Disease Medication Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 43. By Country, North America Coronary Heart Disease Medication Consumption Value Market Share, 2024

Figure 44. Europe Coronary Heart Disease Medication Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 45. By Country, Europe Coronary Heart Disease Medication Consumption Value Market Share, 2024

Figure 46. Asia Pacific Coronary Heart Disease Medication Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 47. By Country/Region, Asia Pacific Coronary Heart Disease Medication Consumption Value Market Share, 2024

Figure 48. South America Coronary Heart Disease Medication Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 49. By Country, South America Coronary Heart Disease Medication Consumption Value Market Share, 2024

Figure 50. Middle East & Africa Coronary Heart Disease Medication Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 51. United States Coronary Heart Disease Medication Sales Quantity, 2020-2031, (K Units)

Figure 52. by Type, United States Coronary Heart Disease Medication Sales Quantity Market Share, 2024 VS 2031

Figure 53. by Application, United States Coronary Heart Disease Medication Sales Quantity Market Share, 2024 VS 2031

Figure 54. Europe Coronary Heart Disease Medication Sales Quantity, 2020-2031, (K Units)

Figure 55. by Type, Europe Coronary Heart Disease Medication Sales Quantity Market Share, 2024 VS 2031

Figure 56. by Application, Europe Coronary Heart Disease Medication Sales Quantity Market Share, 2024 VS 2031

Figure 57. China Coronary Heart Disease Medication Sales Quantity, 2020-2031, (K Units)

Figure 58. by Type, China Coronary Heart Disease Medication Sales Quantity Market Share, 2024 VS 2031

Figure 59. by Application, China Coronary Heart Disease Medication Sales Quantity Market Share, 2024 VS 2031

Figure 60. Japan Coronary Heart Disease Medication Sales Quantity, 2020-2031, (K Units)

Figure 61. by Type, Japan Coronary Heart Disease Medication Sales Quantity Market Share, 2024 VS 2031

Figure 62. by Application, Japan Coronary Heart Disease Medication Sales Quantity Market Share, 2024 VS 2031

Figure 63. South Korea Coronary Heart Disease Medication Sales Quantity, 2020-2031, (K Units)

Figure 64. by Type, South Korea Coronary Heart Disease Medication Sales Quantity Market Share, 2024 VS 2031

Figure 65. by Application, South Korea Coronary Heart Disease Medication Sales Quantity Market Share, 2024 VS 2031

Figure 66. Southeast Asia Coronary Heart Disease Medication Sales Quantity, 2020-2031, (K Units)

Figure 67. by Type, Southeast Asia Coronary Heart Disease Medication Sales Quantity Market Share, 2024 VS 2031

Figure 68. by Application, Southeast Asia Coronary Heart Disease Medication Sales Quantity Market Share, 2024 VS 2031

Figure 69. India Coronary Heart Disease Medication Sales Quantity, 2020-2031, (K Units)

Figure 70. by Type, India Coronary Heart Disease Medication Sales Quantity Market Share, 2024 VS 2031

Figure 71. by Application, India Coronary Heart Disease Medication Sales Quantity Market Share, 2024 VS 2031

Figure 72. Middle East & Africa Coronary Heart Disease Medication Sales Quantity, 2020-2031, (K Units)

Figure 73. by Type, Middle East & Africa Coronary Heart Disease Medication Sales Quantity Market Share, 2024 VS 2031

Figure 74. by Application, Middle East & Africa Coronary Heart Disease Medication Sales Quantity Market Share, 2024 VS 2031

Figure 75. Research Methodology

Figure 76. Breakdown of Primary Interviews

Figure 77. Bottom-up Approaches

Figure 78. Top-down Approaches